Joseph Sparano
MD
Professor, Deputy Director Tisch Cancer Institute
👥Biography 个人简介
Joseph Sparano led the TAILORx trial that validated the 21-gene Oncotype DX recurrence score for guiding adjuvant chemotherapy in HR-positive, HER2-negative, node-negative breast cancer. He is deputy director of the Tisch Cancer Institute at Mount Sinai. His work has changed global adjuvant practice.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Joseph Sparano 的研究动态
Follow Joseph Sparano's research updates
留下邮箱，当我们发布与 Joseph Sparano（Icahn School of Medicine at Mount Sinai）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment